OCT angiography (OCTA): Definition, Uses, and Clinical Overview

OCT angiography (OCTA) Introduction (What it is)

OCT angiography (OCTA) is a non-invasive eye imaging test that maps blood flow in the retina and choroid.
It uses an OCT scanner to create “angiography-like” images without injecting dye.
Clinicians commonly use it in retina clinics to evaluate macular and optic nerve conditions.
It is also used in optometry and ophthalmology settings to monitor vascular changes over time.

Why OCT angiography (OCTA) used (Purpose / benefits)

Many vision-threatening eye diseases affect the tiny blood vessels that nourish the retina (the light-sensing tissue at the back of the eye) and the choroid (a vascular layer beneath the retina). Traditional clinical examination and standard imaging can show structural damage—such as swelling, bleeding, or scarring—but may not fully reveal how blood flow is behaving in the microcirculation.

OCT angiography (OCTA) is used to help clinicians:

• Detect abnormal blood vessel growth (neovascularization) and abnormal vascular networks, especially in the macula (the central retina responsible for detailed vision).
• Evaluate areas of reduced or absent blood flow (non-perfusion/ischemia) that can contribute to retinal dysfunction.
• Differentiate vascular patterns across retinal layers, which can matter for diagnosis and staging.
• Monitor change over time using repeatable scans, supporting longitudinal comparison in chronic diseases.

A practical way to think about OCT angiography (OCTA) is that it complements standard OCT:

• Structural OCT shows the shape and thickness of retinal tissues.
• OCTA shows where blood appears to be moving within retinal and choroidal vessels.

This combination helps clinicians connect symptoms (like blur or distortion) with both tissue changes and microvascular findings, while avoiding dye-based angiography in many situations.

Indications (When ophthalmologists or optometrists use it)

OCT angiography (OCTA) is commonly used in situations such as:

• Suspected or known age-related macular degeneration (AMD), including evaluation for macular neovascularization
• Diabetic retinopathy and diabetic macular changes (assessment of capillary dropout and vascular abnormalities)
• Retinal vein occlusion (branch or central) and related macular findings
• Unexplained central vision loss, distortion (metamorphopsia), or scotomas where macular vascular disease is a concern
• Macular telangiectasia and other macular vascular disorders
• Selected inflammatory/uveitic conditions when vascular involvement is suspected (case dependent)
• Glaucoma and optic nerve assessment in some settings (peripapillary and optic nerve head microvasculature)
• Follow-up imaging to monitor progression or treatment response in established retinal vascular disease (varies by clinician and case)

Contraindications / when it’s NOT ideal

OCT angiography (OCTA) is non-invasive and does not require dye injection, so “contraindications” are usually practical limitations rather than medical prohibitions. It may be less suitable or less informative when:

• Poor image quality is likely, such as with significant cataract, corneal scarring, severe dry eye during scanning, or vitreous hemorrhage (media opacity can reduce signal)
• The patient has difficulty maintaining steady fixation (for example, severe central vision loss, marked nystagmus, tremor, or poor cooperation), increasing motion artifact
• The clinical question requires showing vascular leakage (OCTA visualizes flow signals, but does not directly show dye leakage the way fluorescein angiography does)
• The suspected pathology is primarily far peripheral and outside typical scan areas, unless widefield/montage options are available (availability varies by device and clinic)
• Very slow flow or flow below detection thresholds is suspected, where OCTA may under-represent certain lesions (varies by device settings and condition)
• A clinician needs dynamic information over time (arterial/venous filling sequence), which dye angiography can demonstrate more directly

In these situations, clinicians may rely more on structural OCT, color fundus photography, fluorescein angiography, indocyanine green angiography, or other testing depending on the clinical context.

How it works (Mechanism / physiology)

Mechanism of action / optical principle

OCT angiography (OCTA) is built on optical coherence tomography (OCT), which uses reflected light to create cross-sectional images of retinal tissue. OCTA adds a key step: it takes multiple OCT scans at the same location and compares them.

Blood cells moving through vessels cause small, detectable changes between repeated scans. By analyzing these differences (often described as motion contrast), the system constructs a map of where flow is present.

Relevant eye anatomy and tissues

OCTA is most often used to evaluate:

• Retinal capillary plexuses (commonly segmented into superficial and deep vascular layers)
• The outer retina, which is normally avascular (important because flow signals here can suggest abnormal vessels)
• The choriocapillaris and deeper choroidal circulation
• The optic nerve head and peripapillary microvasculature in selected assessments

Because OCT provides depth-resolved imaging, OCTA can display vascular signals in “slabs” corresponding to different retinal/choroidal layers. This layer-by-layer view is one of its distinctive strengths.

Onset, duration, and reversibility

OCT angiography (OCTA) does not have an onset or duration in the way a medication does. It is a diagnostic imaging method that captures a snapshot of flow-related signals at the time of scanning. Results can change on follow-up because the underlying disease can change and because image quality and segmentation can vary between sessions.

OCT angiography (OCTA) Procedure overview (How it’s applied)

OCT angiography (OCTA) is a diagnostic test performed on an imaging device, typically in an outpatient clinic. A general workflow is:

1. Evaluation/exam
   The clinician reviews symptoms, visual acuity, and the eye exam to decide whether OCTA would add useful information beyond standard OCT and photography.

2. Preparation
   The patient is positioned at the device with a chin rest and forehead support. Pupil dilation may be used in some clinics and not in others, depending on the device, image quality needs, and patient-specific factors (varies by clinician and case).

3. Intervention/testing (imaging acquisition)
   The patient is asked to look at a fixation target while the device captures repeated scans over the area of interest (often the macula and/or optic nerve). Multiple attempts may be taken to improve signal strength and reduce motion artifact.

4. Immediate checks
   Staff or clinicians typically assess scan quality, alignment, and whether motion artifacts or segmentation errors limit interpretability. Additional scans may be obtained if needed.

5. Follow-up
   OCTA images are interpreted alongside structural OCT and the clinical exam. In chronic conditions, repeat imaging may be performed over time to monitor for change (timing varies by clinician and case).

Types / variations

OCT angiography (OCTA) is not a single uniform test; it varies by device technology, scan strategy, and how images are processed and displayed. Common variations include:

• Spectral-domain OCTA vs swept-source OCTA
  These refer to different OCT hardware approaches that can influence scan speed, depth penetration, and sensitivity to choroidal signals. Availability varies by clinic and manufacturer.

• Scan area and field of view
  Smaller scans (often centered on the macula) may provide higher detail, while larger scans can cover more retina but may reduce fine resolution. Some systems offer widefield approaches or montage techniques to extend coverage.

• Anatomic focus

• Macular OCTA for central retinal disease and macular neovascularization

• Optic nerve head/peripapillary OCTA for vascular assessments around the optic nerve (used selectively)

• Layer segmentation (“slabs”) and en face views
  OCTA commonly displays superficial and deep retinal plexuses, outer retina, and choriocapillaris. Segmentation is algorithm-driven and can be affected by retinal swelling, scarring, or high myopia.

• Artifact-reduction and analytics options
  Devices may include features such as projection artifact reduction, motion correction, and quantitative metrics (for example, vessel density). How these are calculated and how reliable they are can vary by device and clinical scenario.

Pros and cons

Pros:

• Non-invasive imaging of retinal and choroidal microvasculature without dye injection
• Provides depth-resolved, layer-by-layer views of vascular flow signals
• Often performed quickly in clinic with repeatable follow-up scans
• Can help detect and monitor macular neovascularization and other vascular abnormalities
• Complements structural OCT by pairing tissue anatomy with flow-related information
• Useful for documenting disease status over time in many chronic retinal conditions

Cons:

• Does not directly show leakage; it maps flow signals rather than dye leakage patterns
• Image quality can be limited by motion artifact, poor fixation, or media opacity (such as cataract or vitreous hemorrhage)
• Segmentation errors can occur, especially when retinal anatomy is distorted by edema, scarring, or advanced disease
• Field of view may be limited compared with some widefield dye angiography approaches (device dependent)
• Flow below detection thresholds may be missed, and some lesions may be under- or over-represented (varies by device and case)
• Interpretation requires context; OCTA findings are typically read alongside exam and other imaging rather than in isolation

Aftercare & longevity

There is typically minimal “aftercare” after OCT angiography (OCTA) because it is an imaging test rather than a treatment. Practical factors that influence how useful the results are—and how meaningful comparisons are over time—include:

• Underlying condition severity and activity
  Vascular patterns can evolve with disease progression or stabilization, so follow-up images may look different over weeks to months (timing varies by clinician and case).

• Consistency of imaging conditions
  Similar scan size, centering, and signal quality improve comparisons between visits. Differences in fixation, dryness, or media clarity can change scan appearance.

• Ocular surface health during scanning
  Tear film instability can reduce image quality. In real-world clinics, technicians may repeat scans to improve clarity if the first capture is suboptimal.

• Comorbidities
  Cataract, corneal disease, vitreous opacities, and severe macular scarring can reduce signal and limit interpretability.

• Device/software and analysis method
  Quantitative metrics and layer segmentation can differ across manufacturers and software versions, which can affect longitudinal comparisons if imaging is performed on different platforms.

In terms of “longevity,” OCTA does not provide a permanent effect—its value is in documentation and monitoring. The appropriate interval for repeat imaging depends on the clinical question and is determined by the treating clinician (varies by clinician and case).

Alternatives / comparisons

OCT angiography (OCTA) is one tool among several retinal imaging options. Clinicians choose among them based on what they need to see—structure, leakage, perfusion, peripheral retina, or change over time.

• Structural OCT (standard OCT) vs OCTA
  Structural OCT excels at showing retinal thickness, fluid, and layers (for example, macular edema or subretinal fluid). OCTA adds flow information but may not explain symptoms if the issue is primarily structural without a vascular component.

• Fluorescein angiography (FA) vs OCTA
  FA uses intravenous dye and can show leakage, pooling, and dynamic filling patterns over time. OCTA avoids dye and provides depth-resolved vascular maps, but it does not directly display leakage and can be affected by artifacts. In some clinical questions, FA remains important; in others, OCTA may reduce the need for dye-based testing.

• Indocyanine green angiography (ICGA) vs OCTA
  ICGA (a dye test) is often used for choroidal circulation and certain neovascular conditions. Swept-source OCTA can improve choroidal visualization compared with some other OCTA approaches, but ICGA may still be selected when dye-based choroidal imaging is required (varies by clinician and case).

• Color fundus photography vs OCTA
  Photography documents visible retinal findings (hemorrhages, exudates, pigment changes) but does not map microvascular flow. OCTA adds a different type of information and is often used alongside photos.

• Clinical observation/monitoring vs OCTA
  Some patients can be monitored with exam and structural OCT alone. OCTA is more likely to be added when vascular detail could change diagnosis, staging, or monitoring strategy.

OCT angiography (OCTA) Common questions (FAQ)

Q: Is OCT angiography (OCTA) painful?
OCTA is generally comfortable because it is an imaging scan that uses light and does not involve needles or contact with the eye in most routine setups. You may notice bright lights and the need to keep your eye steady. Discomfort is more commonly related to keeping the eye open and focused rather than pain.

Q: Do I need my pupils dilated for OCT angiography (OCTA)?
Some clinics perform OCTA without dilation, while others dilate to improve image quality or make scanning easier. Whether dilation is used depends on the device, scan goals, and the patient’s pupil size and media clarity. Varies by clinician and case.

Q: How long does the test take?
The scanning itself is often brief, but total time can include check-in, positioning, repeating scans for quality, and review. If dilation is done, that can add waiting time. The overall visit length varies by clinic workflow.

Q: What does OCT angiography (OCTA) show that regular OCT does not?
Regular OCT primarily shows retinal structure—thickness, swelling, and layers. OCTA adds maps of flow-related signals in retinal and choroidal vessels, often separated by depth (layer). In many cases, clinicians interpret OCT and OCTA together to connect anatomy with vascular findings.

Q: Can OCT angiography (OCTA) replace fluorescein angiography?
Sometimes OCTA can provide enough information to answer the clinical question without dye testing, especially for certain macular vascular assessments. However, fluorescein angiography directly demonstrates leakage and dynamic filling, which OCTA does not. Whether one can replace the other depends on the suspected condition and the information needed.

Q: Is OCT angiography (OCTA) safe?
OCTA is widely used and is considered low risk because it does not require dye injection and is non-invasive. The main issues are typically practical—image quality limitations, motion artifacts, or difficulty fixating. Individual circumstances can differ, so clinicians choose tests accordingly.

Q: Will I be able to drive after the appointment?
If your eyes are dilated, your vision may be blurry and light-sensitive for a period of time, which can affect driving. If dilation is not performed, many people can resume usual activities right away. Policies and individual experiences vary.

Q: Can I use screens or read after OCT angiography (OCTA)?
Most people can return to normal screen use and reading immediately after the scan itself. If dilation was used, near vision may be temporarily blurred and bright screens may feel more uncomfortable until dilation wears off. These effects are related to dilation rather than OCTA.

Q: How long do OCT angiography (OCTA) results “last”?
OCTA results reflect blood-flow signals at the time of imaging, so they do not “last” in the way a treatment does. The usefulness of a scan depends on how stable or active the underlying condition is and how it changes over time. Repeat imaging is often used for monitoring when clinically relevant.

Q: How much does OCT angiography (OCTA) cost?
Costs vary widely by country, clinic setting, insurance coverage, and whether OCTA is billed separately or bundled with other retinal imaging. Some practices perform OCTA as part of a broader diagnostic evaluation, while others use it selectively. For specifics, patients typically need to ask the imaging center or insurer.